Aandelen in “Biotechnologie”

Aandeel Datum Koers Evolutie
Even geduld...

Nieuws over “Biotechnologie”

07:00 · Addex to Present at the Swiss Biotech Day 2024 · Persbericht

07:00 · Addex to Present at the Swiss Biotech Day 2024 · Persbericht

18/04 · BLUE Investors Have Opportunity to Lead bluebird bio, Inc. Securities Fraud Lawsuit · Persbericht

18/04 · Pharming Group announces the placement of €100 million convertible bonds due 2029 · Persbericht

18/04 · Renovaro Inc. Proudly Announces the Appointment Of Professor Dr. Geert Kazemier as the Chairman of its Scientific Advisory Board, A Move That Heralds a New Era of Innovation and Progress in its Mission to Reshape Cancer Screening, Diagnosis, and Patient Care · Persbericht

18/04 · AvidXchange CEO Shares His Vision for Revolutionizing Software-Enabled Payments on Today's Marketplace · Persbericht

18/04 · Soligenix Announces Pricing of $4.75 Million Public Offering · Persbericht

18/04 · Anixa Biosciences Welcomes Celebrity Oncologist Dr. Sanjay Juneja to its Cancer Business Advisory Board · Persbericht

18/04 · Blueprint Medicines to Report First Quarter 2024 Financial Results on Thursday, May 2, 2024 · Persbericht

18/04 · Poseida Therapeutics Announces Strong Lineup of Presentations at the American Society of Gene and Cell Therapy 27th Annual Meeting · Persbericht

18/04 · EVOTEC AND VARIANT BIO ENTER STRATEGIC PARTNERSHIP TO DISCOVER AND DEVELOP FIBROSIS TREATMENTS · Persbericht

18/04 · Pharming Group announces the launch of an offering of approximately €100 million convertible bonds due 2029 and the concurrent repurchase of the outstanding €125 million convertible bonds due 2025 · Persbericht

18/04 · BioSenic S.A. : Transparency notifications received from François Rieger · Persbericht

18/04 · Addex Therapeutics Reports Full Year 2023 Financial Results and Provides Corporate Update · Persbericht

18/04 · INVESTIGATION: The M&A Class Action Firm Announces an Investigation of Alpine Immune Sciences, Inc. - ALPN · Persbericht

18/04 · SHAREHOLDER INVESTIGATION: The M&A Class Action Firm Continues Investigating the Merger - BCEL, CTLT, NS, SCX · Persbericht

17/04 · NANOBIOTIX to Announce Fourth Quarter and Full Year 2023 Operational and Financial Update on April 24, 2024 · Persbericht

17/04 · Viking Therapeutics to Report Financial Results for First Quarter 2024 on April 24, 2024 · Persbericht

17/04 · Alkermes to Report First Quarter Financial Results on May 1, 2024 · Persbericht

17/04 · Vanda Pharmaceuticals Adopts Limited Duration Stockholder Rights Plan · Persbericht

17/04 · Vanda Pharmaceuticals Confirms Rejection of Unsolicited Takeover Proposals from Future Pak · Persbericht

Mijn selecties